Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: Implications for HIV-associated neurodegeneration

Experimental Neurology

Volumn 236, Issue 2, 2012, Pages 298-306

  Banerjee, Sugato ^a   Liao, Lujian ^b   Russo, Rossella ^a,c   Nakamura, Tomohiro ^a   McKercher, Scott R ^a   Okamoto, Shu ichi ^a   Haun, Florian ^a   Nikzad, Rana ^a   Zaidi, Rameez ^a   Holland, Emily ^a   Eroshkin, Alexey ^a   Yates, John R ^b   Lipton, Stuart A ^a  

^a BURNHAM INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Akt; Gp120; HIV 1; Proteomics; S nitrosylation; Synaptosomes; Tandem mass tag labeling for Mass Spectrometry

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ALBUMIN; APOLIPOPROTEIN O; BETA ARRESTIN 1; CALPAIN 2; CARNITINE ACETYLTRANSFERASE; CELL MARKER; CELL PROTEIN; CHLORIDE CHANNEL 6; CLATHRIN HEAVY CHAIN; CORNICHON HOMOLOG 3; DYNACTIN 2; EXOCYST COMPLEX COMPNENT 1; FRATAXIN; GELSOLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; ISLET CELL AUTOANTIGEN 1; LATEXIN; LIPOCORTIN 5; NEUROCHONDRIN; OXYSTEROL BINDING PROTEIN; PARALEMMIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B; ROOTLETIN; SERINE PROTEINASE 2; SORTING NEXIN 4; SYNAPTOTAGMIN XII; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AUTOPSY; BIOINFORMATICS; BRAIN CORTEX; CELL SURVIVAL; CHEMICAL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG TARGETING; ENZYME INACTIVATION; ENZYME INHIBITION; FEMALE; FOREBRAIN; HIV ASSOCIATED DEMENTIA; HIV GP120 TRANSGENIC MOUSE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; ISOBARIC TAGGING; MALE; MASS SPECTROMETER; MICROGLIA; MOUSE; MOUSE STRAIN; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NITROSYLATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SYNAPSE; SYNAPTOSOME; TANDEM MASS SPECTROMETRY; TANDEM MASS TAG LABELING; TRANSGENIC MOUSE;

ADULT; AGED; ANIMALS; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; NEURAL PATHWAYS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; SYNAPTOSOMES; TANDEM MASS SPECTROMETRY; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS INACTIVATION;

EID: 84862269346     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.04.013     Document Type: Article

References (38)

1. Borderies G., Le Bechec M., Rossignol M., Lafitte C., Le Deunff E., Beckert M., Dumas C., Elisabeth M.R. Characterization of proteins secreted during maize microspore culture: arabinogalactan proteins (AGPs) stimulate embryo development. Eur. J. Cell Biol. 2004, 83:205-212.
2. Carlin R.K., Grab D.J., Cohen R.S., Siekevitz P. Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J. Cell Biol. 1980, 86:831-845.
3. Che F.Y., Fricker L.D. Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J. Mass Spectrom. 2005, 40:238-249.
4. Cherner M., Masliah E., Ellis R.J., Marcotte T.D., Moore D.J., Grant I., Heaton R.K. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 2002, 59:1563-1567.
5. Cohen S.A., Fischbach G.D. Clusters of acetylcholine receptors located at identified nerve-muscle synapses in vitro. Dev. Biol. 1977, 59:24-38.
6. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647.
7. Digicaylioglu M., Kaul M., Fletcher L., Dowen R., Lipton S.A. Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage. Neuroreport 2004, 15:761-763.
8. Digicaylioglu M., Garden G., Timberlake S., Fletcher L., Lipton S.A. Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9855-9860.
9. Eng J.M., McCormack A.L., Yates J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5:976-989.
10. Garden G.A., Budd S.L., Tsai E., Hanson L., Kaul M., D'Emilia D.M., Friedlander R.M., Yuan J., Masliah E., Lipton S.A. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J. Neurosci. 2002, 22:4015-4024.
11. Gorantla S., Liu J., Sneller H., Dou H., Holguin A., Smith L., Ikezu T., Volsky D.J., Poluektova L., Gendelman H.E. Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J. Immunol. 2007, 179:4345-4356.
12. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17:994-999.
13. Hansson E., Ronnback L. Glial neuronal signaling in the central nervous system. FASEB J. 2003, 17:341-348.
14. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 2001, 3:193-197.
15. Kang Y.J., Digicaylioglu M., Russo R., Kaul M., Achim C.L., Fletcher L., Masliah E., Lipton S.A. Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders. Ann. Neurol. 2010, 68:342-352.
16. Kaul M., Ma Q., Medders K.E., Desai M.K., Lipton S.A. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 2007, 14:296-305.
17. Kennedy M.B., Bennett M.K., Erondu N.E. Biochemical and immunochemical evidence that the "major postsynaptic density protein" is a subunit of a calmodulin-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:7357-7361.
18. Kermer P., Klocker N., Labes M., Bahr M. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 In vivo. J. Neurosci. 2000, 20:2-8.
19. Kolson D.L. Neuropathogenesis of central nervous system HIV-1 infection. Clin. Lab. Med. 2002, 22:703-717.
20. Li X., Lu Y., Jin W., Liang K., Mills G.B., Fan Z. Autophosphorylation of Akt at Threonine 72 and Serine 246: a potential mechanism of regulation of Akt kinase activity. J. Biol. Chem. 2006, 281:13837-13843.
21. McArthur J.C. HIV dementia: an evolving disease. J. Neuroimmunol. 2004, 157:3-10.
22. McArthur J.C., Steiner J., Sacktor N., Nath A. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann. Neurol. 2010, 67:699-714.
23. Meucci O., Fatatis A., Simen A.A., Miller R.J. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8075-8080.
24. Moore D.J., Masliah E., Rippeth J.D., Gonzalez R., Carey C.L., Cherner M., Ellis R.J., Achim C.L., Marcotte T.D., Heaton R.K., Grant I. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 2006, 20:879-887.
25. Nitta A., Zheng W.H., Quirion R. Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway. J. Neurosci. Res. 2004, 76:98-103.
26. Numajiri N., Takasawa K., Nishiya T., Hayakawa W., Asada M., Matsuda H., Azumi K., Tanaka H., Hyakkoku K., Kamata H., Nakamura T., Hara H., Minami M., Lipton S.A., Uehara T. On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN). Proc. Natl. Acad. Sci. USA 2011, 108:10349-10354.
27. Park S.K., Venable J.D., Xu T., Yates J.R. A quantitative analysis software tool for mass spectrometry-based proteomics. Nat. Methods 2008, 5:319-322.
28. Potula R., Poluektova L., Knipe B., Chrastil J., Heilman D., Dou H., Takikawa O., Munn D.H., Gendelman H.E., Persidsky Y. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 2005, 106:2382-2390.
29. Ross A., Kessler W., Krumme D., Menge U., Wissing J., van den Heuvel J., Flohe L. Optimised fermentation strategy for 13C/15N recombinant protein labelling in Escherichia coli for NMR-structure analysis. J. Biotechnol. 2004, 108:31-39.
30. Schifitto G., Navia B.A., Yiannoutsos C.T., Marra C.M., Chang L., Ernst T., Jarvik J.G., Miller E.N., Singer E.J., Ellis R.J., Kolson D.L., Simpson D., Nath A., Berger J., Shriver S.L., Millar L.L., Colquhoun D., Lenkinski R., Gonzalez R.G., Lipton S.A. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 2007, 21:1877-1886.
31. Schrimpf S.P., Meskenaite V., Brunner E., Rutishauser D., Walther P., Eng J., Aebersold R., Sonderegger P. Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry. Proteomics 2005, 5:2531-2541.
32. Tabb D.L., McDonald W.H., Yates J.R. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J.Proteome Res. 2002, 1:21-26.
33. Thorne R.G., Pronk G.J., Padmanabhan V., Frey W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004, 127:481-496.
34. Toggas S.M., Masliah E., Rockenstein E.M., Rall G.F., Abraham C.R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994, 367:188-193.
35. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19:242-247.
36. Witzman F.A., Arnold R.J., Bai F., Hrncirova P., Kimpel M.W., Mechref Y.S., McBride W.J., Novotny M.V., Pedrick N.M., Ringham H.N., Simon J.R. A proteomic survey of rat cerebral cortical synaptosomes. Proteomics 2005, 5:2177-2201.
37. Yao H., Peng F., Dhillon N., Callen S., Bokhari S., Stehno-Bittel L., Ahmad S.O., Wang J.Q., Buch S. Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity. J. Neurosci. 2009, 29:1657-1669.
38. Yasukawa T., Tokunaga E., Ota H., Sugita H., Martyn J.A., Kaneki M. S-Nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J. Biol. Chem. 2005, 280:7511-7518.